Crestline Management, LP is 10% Owner at Denali Therapeutics Inc. (DNLI). They have made 1 open-market trade across 1 company since 2020, most recently 2020-08-12.
CIK 0001536054
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNLI | 12,201,634 | $214.8M |
Shares reported on the most recent Form 4, priced at the 2020-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNLI | SELL | 2020-08-12 | 2020-08-14 | $31.65 | $91.4M | +6.1% | +17.9% | +128.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.